1 |
Peng J, Chen Q, Wu C. The role of adiponectin in cardiovascular disease. Cardiovasc Pathol 2023;64:107514. [PMID: 36634790 DOI: 10.1016/j.carpath.2022.107514] [Reference Citation Analysis]
|
2 |
Han W, Yang S, Xiao H, Wang M, Ye J, Cao L, Sun G. Role of Adiponectin in Cardiovascular Diseases Related to Glucose and Lipid Metabolism Disorders. Int J Mol Sci 2022;23. [PMID: 36555264 DOI: 10.3390/ijms232415627] [Reference Citation Analysis]
|
3 |
Xu Y, Zhu H, Li W, Chen D, Xu Y, Xu A, Ye D. Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies. Pharmacol Ther 2022;240:108284. [PMID: 36162728 DOI: 10.1016/j.pharmthera.2022.108284] [Reference Citation Analysis]
|
4 |
Nehme R, Diab-Assaf M, Decombat C, Delort L, Caldefie-Chezet F. Targeting Adiponectin in Breast Cancer. Biomedicines 2022;10. [PMID: 36428526 DOI: 10.3390/biomedicines10112958] [Reference Citation Analysis]
|
5 |
Xia W, Li X, Wu Q, Xu A, Zhang L, Xia Z. The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.951381] [Reference Citation Analysis]
|
6 |
Dabravolski SA, Sadykhov NK, Kartuesov AG, Borisov EE, Sukhorukov VN, Orekhov AN. The Role of Mitochondrial Abnormalities in Diabetic Cardiomyopathy. Int J Mol Sci 2022;23:7863. [PMID: 35887211 DOI: 10.3390/ijms23147863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|